Ernexa Therapeutics (ERNA) Gross Margin (2009 - 2024)
Ernexa Therapeutics (ERNA) posted Gross Margin of 5.26% for Q4 2024, up 105.26 percentage points from -100.00% a year earlier but down 107.06 percentage points from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Gross Margin (2009 - 2024) Analysis & Trends
For FY2024, Ernexa Therapeutics' Gross Margin came in at 81.00%, up 249.00 percentage points from FY2023.
- Annual Gross Margin shows a five-year change of +18.78 percentage points (FY2019 to FY2024).
- In prior years, Ernexa Therapeutics' Gross Margin was -168.00% in FY2023 and 49.88% in FY2020 (-12.34 pp).
- Quarterly Gross Margin has run from a low of -135.29% in Q3 2023 to a high of 112.32% in Q3 2024 over five years.
- According to Business Quant data, Gross Margin for the three prior quarters was 112.32% (Q3 2024), -102.13% (Q2 2024) and -29.79% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Ernexa Therapeutics | 3.31 Mn | -18.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 5.26% |
| Sep 30, 2024 | 112.32% |
| Jun 30, 2024 | -102.13% |
| Mar 31, 2024 | -29.79% |
| Dec 31, 2023 | -100.00% |
| Sep 30, 2023 | -135.29% |
| Dec 31, 2020 | 53.79% |
| Sep 30, 2020 | 45.77% |
| Jun 30, 2020 | -198.54% |
| Mar 31, 2020 | -79.53% |
| Dec 31, 2019 | 43.15% |
| Sep 30, 2019 | 70.66% |
| Jun 30, 2019 | 67.15% |
| Mar 31, 2019 | 69.29% |
| Dec 31, 2018 | 65.35% |
| Sep 30, 2018 | 64.77% |
| Jun 30, 2018 | 65.72% |
| Mar 31, 2018 | 65.86% |
| Dec 31, 2017 | 67.11% |
| Sep 30, 2017 | 70.39% |
API Access
Ernexa Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();